Technical Analysis for IMNM - Immunome, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | Up | Up |
Historical IMNM trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
180 Bullish Setup | Bullish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Slingshot Bullish | Bullish Swing Setup | 3.53% | |
Wide Bands | Range Expansion | 3.53% | |
Overbought Stochastic | Strength | 3.53% | |
New 52 Week Closing High | Bullish | -3.55% | |
Narrow Range Bar | Range Contraction | -3.55% | |
NR7 | Range Contraction | -3.55% | |
Upper Bollinger Band Walk | Strength | -3.55% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Up 3% | 1 day ago | |
Up 2% | 1 day ago | |
Up 1% | 1 day ago | |
60 Minute Opening Range Breakout | 1 day ago | |
Down 2 % | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibodies Monoclonal Antibody Cancer Immunotherapy Multiplex Tumor Antibody Glycoproteins Antigen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibodies Monoclonal Antibody Cancer Immunotherapy Multiplex Tumor Antibody Glycoproteins Antigen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.77 |
52 Week Low | 9.27 |
Average Volume | 64,084 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 11.46 |
20-Day Moving Average | 11.82 |
10-Day Moving Average | 13.76 |
Average True Range | 0.97 |
ADX | 31.87 |
+DI | 31.47 |
-DI | 15.30 |
Chandelier Exit (Long, 3 ATRs ) | 12.45 |
Chandelier Exit (Short, 3 ATRs ) | 12.19 |
Upper Bollinger Band | 15.98 |
Lower Bollinger Band | 7.65 |
Percent B (%b) | 0.84 |
BandWidth | 70.48 |
MACD Line | 1.00 |
MACD Signal Line | 0.59 |
MACD Histogram | 0.4148 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.22 | ||||
Resistance 3 (R3) | 16.11 | 15.49 | 15.97 | ||
Resistance 2 (R2) | 15.49 | 15.09 | 15.54 | 15.88 | |
Resistance 1 (R1) | 15.08 | 14.85 | 15.28 | 15.19 | 15.79 |
Pivot Point | 14.46 | 14.46 | 14.56 | 14.51 | 14.46 |
Support 1 (S1) | 14.05 | 14.06 | 14.26 | 14.17 | 13.57 |
Support 2 (S2) | 13.43 | 13.82 | 13.48 | 13.48 | |
Support 3 (S3) | 13.03 | 13.43 | 13.39 | ||
Support 4 (S4) | 13.14 |